Prof. Valeria Santini, in her article published on Lancet Oncology, presents the clinical study of dr. Uwe Platzbecker focused on MDS low risk patient treated with a new drug: Luspatercept.
Here there is a video of Prof. Santini interviewed by Pharmastar during the last EHA Congress in Madrid ( June 2017): she talks about Luspatercept.